510(k) device
Ceribell Status Epilepticus Monitor
Ceribell, Inc. · Automatic Event Detection Software For Full-Montage Electroencephalograph (OMB, Class II) · First FDA decision May 23, 2023, newest May 23, 2023Epilepsy
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
Breakthrough-designated
Device trials
11
Naming "Status Epilepticus"
MAUDE reports
0
Brand "Status Epilepticus", since 2015
PubMed studies
17,670
Mentioning "Status Epilepticus"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Ceribell Status Epilepticus Monitor
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Ceribell Status Epilepticus MonitorBreakthrough510(k)
K223504 · Decided May 23, 2023 · 182 days after receipt
Device type: Automatic Event Detection Software For Full-Montage Electroencephalograph (OMB) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Status Epilepticus", any status and sponsor, newest update first.
- Acute Effects of Focused Ultrasound Modulation on EEG Behavior in Status Epilepticus PatientsRecruiting
Yale UniversityAcademic, hospital or other
NCT05784805 · 10 participants (planned) · Start Jun 24, 2023 · Primary completion Dec 2026
Device: PLIFU · For: Seizures
Sites: New Haven, Connecticut
Xuanwu Hospital, BeijingAcademic, hospital or other
NCT06344338 · 32 participants (planned) · Start Apr 1, 2024 · Primary completion Oct 1, 2026
Device: tDCS stimulation; TDCS sham-stimulation · For: Refractory Status Epilepticus
Sites: Beijing, China
- Targeted Hypothermia Versus Targeted Normothermia After Convulsive Refractory Status EpilepticusPivotal-lookingNot yet recruiting
Versailles HospitalAcademic, hospital or other
NCT07383779 · 466 participants (planned) · Start Mar 1, 2026 · Primary completion Jun 1, 2029
Device: Targeted Hypothermia · For: Convulsive Refractory Status Epilepticus; Status Epilepticus
Sites: Boulogne-Billancourt, France; Brest, France; Cannes, France · 20 sites in all
8 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Status Epilepticus", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code OMB
33 reports: 32 malfunction, 0 injury, 1 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Status Epilepticus"[tiab]. The summary above synthesizes these.
- Status Epilepticus: A Neurologic Emergency.
Coppler PJ, Elmer J · Crit Care Clin · 2023Review
- Status Epilepticus.
Siegel CR, Khoujah D · Emerg Med Clin North Am · 2026Review
- Initial Management of Acute Seizures and Status Epilepticus.
Haider HA · Med Clin North Am · 2025Review
- Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions.
Hirsch LJ, Gaspard N, van Baalen A, et al. · Epilepsia · 2018Research Support, Non-U.S. Gov't, Review
- Status epilepticus special edition.
Sen A · Seizure · 2020Editorial, Introductory Journal Article
- Status epilepticus.
Lowenstein DH, Alldredge BK · N Engl J Med · 1998Research Support, U.S. Gov't, P.H.S., Review
- [Status epilepticus].
Gonçalves M, Almeida R, Viana JP · Acta Med Port · 1996English Abstract, Review
- [Status epilepticus].
Burghaus L, Dohmen C, Malter M · Fortschr Neurol Psychiatr · 2018Review
- Imipramine-precipitated status epilepticus.
Naguy A · World J Pediatr · 2021Case Reports, Letter
- Status Epilepticus in Children.
Zimmern V, Korff C · J Clin Neurophysiol · 2020Review
- Linezolid-induced status epilepticus.
Rival M, Chetioui A, Tailland M, et al. · Acta Neurol Belg · 2020Case Reports, Letter
- Refractory status epilepticus.
Singh SP, Agarwal S, Faulkner M · Ann Indian Acad Neurol · 2014
Other devices of this type
Also filed under product code OMB.
- Persyst 15 EEG Review and Analysis Software (Persyst 15 (P15))Persyst Development, LLC · 510(k) 2025
- autoSCORE (V 2.0.0)Holberg Eeg AS · 510(k) 2025
- encevis (2.1)Ait Austrian Institute of Technology GmbH · 510(k) 2024
- Natus NeuroWorksNatus Medical Incorporated Dba Excel-Tech Ltd. (Xltek) · 510(k) 2020
- Ceribell Neurology Review SoftwareCeribell, Inc. · 510(k) 2026
- Ceribell Infant Seizure Detection SoftwareCeribell, Inc. · 510(k) 2025
- Ceribell Seizure Detection SoftwareCeribell, Inc. · 510(k) 2025
- NeuroMatchLVIS Corporation · 510(k) 2024
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.